Access to unique germplasm for selection of elite medical cannabis clones for the yield of therapeutically active major and minor cannabinoids.

Use of state-of-the-art physical and intellectual infrastructure for optimisation of agronomic parameters for elite medicinal cannabis chemovars.

Scale up production of unique pharmaceutically active chemovars in Greenlab commercial cultivation division.